American Vanguard Corporation Common Stock ($0.10 Par Value) (AVD)
AVD trades on NYSE in Industrials, Agricultural Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.33
-5.67% on the day
Market cap
$39.2M
Nano cap
Revenue · 2025
$515.1M
-5.9% on 2024
Net income · 2025
-$49.9M
-9.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | AVD on NYSE |
| Sector | Industrials |
| Industry | Agricultural Chemicals |
| Country | United States |
| IPO year | 1998 |
| SEC CIK | 0000005981 |
| SEC industry code | Agricultural Chemicals |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $515.1M |
| Net income | -$49.9M |
| Operating income | -$28.3M |
| Net margin | -9.7% |
| Operating margin | -5.5% |
| Revenue growth | -5.9% |
| Cash | Not in SEC XBRL data |
| Total assets | $596.5M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 10-K/A | 2026-09-30 |
| Latest quarterly / interim | 10-Q | 2026-08-10 |
| Latest current report | 8-K | 2026-10-01 |
| Latest proxy | DEF 14A | 2026-04-23 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Agricultural Chemicals
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BIOX | Bioceres Crop Solutions Corp. | $0.3250 | -1.81% | $20.7M |
| CBUS | Cibus Inc. | $1.41 | -4.73% | $107.8M |
| FRTT | Fort Technology Inc. Common Shares | $0.6960 | -7.08% | $10.5M |
| EVGN | Evogene Ltd | $0.3902 | +0.96% | $6.2M |
| SNES | SenesTech Inc. | $0.6293 | -2.87% | $3.4M |
| UAN | CVR Partners LP Common Units representing Limited Partner Interests | $126.21 | +0.57% | $1.3B |
| NXTS | Nexentis Technologies Inc. | $0.7038 | -6.88% | $1.0M |
| SMG | Scotts Miracle-Gro Company (The) | $50.10 | +0.32% | $2.9B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier